Revolutionizing Schizophrenia Treatment with Aripiprazole Long-Acting Injections
Schizophrenia, a chronic and severe mental disorder, impacts millions globally, reducing life expectancy and quality of life for those affected. Traditional treatments have faced challenges, notably medication adherence. However, the advent of Aripiprazole Long-Acting Injectable (LAI), known commercially as Abilify Maintena®, marks a significant advancement in the management of this condition. This article delves into …